Contact Us
Drug Search Results
More Filters [+]

Glutaral

Alternative Names: glutaral, ginkgo biloba extract
Latest Update: 2024-08-21
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: P-gp Inhibitor,TNF Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Argentina | Australia | Chile | Colombia | Dominican Republic | Germany | India | Ireland | Korea | Lebanon | Malaysia | Mexico | Morocco | Pakistan | Peru | Russia | Spain | Taiwan | Thailand | Turkey | United Arab Emirates | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Amen Clinics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Glutaral

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Cognitive Dysfunction|Glaucoma|Myocardial Ischemia|Coronary Artery Disease|Type 2 Diabetes

Phase 3: Cognitive Dysfunction|Dementia|Memory Disorders|Tinnitus

Phase 2: Raynaud Disease|Fetal Growth Retardation|Hearing Loss|Insulin Resistance|Type 2 Diabetes

Phase 1: Coronary Disease|Angina Pectoris

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
BEFIT

N/A

Not yet recruiting

Ischemic Stroke

2026-10-01

GRACE

P4

Not yet recruiting

Cognitive Dysfunction

2025-12-31

ChiCTR2200063158

N/A

Not yet recruiting

Unknown

2024-12-31

AgilGinkgo

N/A

Active, not recruiting

Cognitive Dysfunction

2024-05-31

Recent News Events

Date

Type

Title

06/01/2024

PubMed

 Pepsin immobilization on activated carbon and functionalized with glutaraldehyde and genipin for the synthesis of antioxidant peptides of goat casein.

05/14/2024

PubMed

 Natural Antioxidants: An Effective Strategy for the Treatment of Alzheimer's Disease at the Early Stage.

04/23/2024

PubMed

 L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism.

10/03/2023

News Article

 Blood Thinner Market 2023 Trends, Development, Revenue, Production, Types, Applications, Demand and Forecast to 2030

09/25/2023

News Article

 Ginkgo Biloba Extract Market Size, Regional Overview, and Future Outlook [2023-2030]

09/13/2023

News Article

 Ginkgo Biloba Extract Market Share 2023 Forecast 2031

09/12/2023

News Article

 2023 Transistor Amplifier Market Strategies 2030

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions